How can controlled human infection models accelerate clinical development and policy pathways for vaccines against Shigella? by Giersing, B, Porter, C, Kotloff, K, Neels, P, Cravioto, A, Maclennan, C

Update on the clinical development of candidate malaria vaccines. by Ballou, W, Arevalo-Herrera, M, Carucci, D, Richie, T, Corradin, G, Diggs, C, Druilhe, P, Giersing, B, Saul, A, Heppner, D, Kester, K, Lanar, D, Lyon, J, Hill, A, Pan, W, Cohen, J